PreveCeutical™ Medical Inc. Launches Phase One of Venom Re-Engineering Project
25. Juli 2017 08:30 ET
|
PreveCeutical Medical Inc
VANCOUVER, British Columbia, July 25, 2017 (GLOBE NEWSWIRE) -- PreveCeutical Medical Inc. (the “Company” or “PreveCeutical”) (CSE:PREV) announces the launch of the Company’s multi-faceted Research...